These patients were associated with a defective LDL-receptor mutation, higher levels of high-density lipoprotein, younger age, lower score on the SAFEHEART risk equation, absence of hypertension, and lower lipoprotein A levels. This evidence concerns the gene LDLR and hypertensive disorder.